ClinConnect ClinConnect Logo
Search / Trial NCT06426862

Effects of Otago Exercise Program in Falls, Balance and Physical Performance in Stroke Patients

Launched by RIPHAH INTERNATIONAL UNIVERSITY · May 19, 2024

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Stroke Cardiovascular Attack Otago Exercise Program Berg Balance Scale Time Up & Go Test Fugl Meyer Assessment

ClinConnect Summary

This clinical trial is studying the Otago Exercise Program (OEP) to see how it affects falls, balance, and overall physical performance in patients who have had a stroke. The trial will include two groups: one group will participate in the OEP, while the other group will not. Researchers will evaluate the participants' balance and physical ability using simple tests over the course of a week.

To be eligible for the trial, participants must be at least 40 years old and have experienced a stroke within the last six months. They should also have certain balance and mobility scores that indicate they could benefit from the exercise program. However, individuals with cognitive difficulties, significant physical disabilities other than from the stroke, recent surgeries, or certain health conditions like heart or lung diseases will not be included. If you or someone you know meets these criteria, this study could be a valuable opportunity to improve balance and reduce the risk of falls after a stroke.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Ischemic or hemorrhagic stroke
  • Medically stable patients with acute to subacute level of stroke recovery (\< 6 month).
  • Patients 40 plus age
  • Berg balance scale \<45 and \>20 score
  • TUG test scoring \>20 sec
  • Exclusion Criteria:
  • Participants having cognition problem or language barrier
  • Physical disability (fracture or amputation) other than stroke
  • Previous surgery 6 weeks
  • Cardiovascular and pulmonary disease

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Peshawar, Kpk, Pakistan

Patients applied

0 patients applied

Trial Officials

IMRAN AMJAD, PhD

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported